19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACIN, with a corresponding application number 20381.
Regulatory Information DISCN
With a dosage strength 375MG;500MG;750MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 1997-07-28
18
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACIN, with a corresponding application number 20381.
Regulatory Information DISCN
With a dosage strength 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 1997-07-28
17
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACIN, with a corresponding application number 20381.
Regulatory Information DISCN
With a dosage strength 375MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 1997-07-28
16
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACIN, with a corresponding application number 20381.
Regulatory Information DISCN
With a dosage strength 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 1997-07-28
15
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NIACIN, with a corresponding application number 20381.
Regulatory Information DISCN
With a dosage strength 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 1997-07-28